Keywords: Merck & Co, AIDS drug pricing, Isentress, AHF, USA

Merck slammed over drug pricing

Article | 12 December 2011

Print This

In another swipe at US pharma giant Merck & Co (NYSE: MRK), the AIDS Healthcare Foundation (AHF) has launched a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in